|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$6.64 |
$7.01 |
$6.60 |
$6.85 |
347.60K | 04/22/2024 |
$6.92 |
$7.34 |
$6.82 |
$7.17 |
192.60K | 04/23/2024 |
$7.03 |
$7.43 |
$6.85 |
$6.96 |
185.20K | 04/24/2024 |
$6.93 |
$7.32 |
$6.88 |
$7.06 |
153.40K | 04/25/2024 |
$6.96 |
$6.97 |
$6.47 |
$6.56 |
328.80K |
|
Actinium Pharmaceuticals is a clinical-stage biopharmaceutical company. Co.'s targeted radiotherapies combine the cell-killing ability of radiation via a radioisotope payload with a targeting agent to deliver radiation in a precise manner inside the body to specific targeted cells. Co.'s Iomab-B and Actimab-A product candidates are focused on addressing the medical needs in relapsed or refractory acute myeloid leukemia (AML) in a complementary manner and are directed at different parts of the patient journey. Iomab-B is a targeted radiotherapy consisting of apamistamab. Actimab-A (225Ac-lintuzumab satetraxetan) program is focused on developing combinations with other AML treatment regimens. | |
|
Actinium Pharmaceuticals (ATNM) has the following price history information. Looking back at ATNM historical stock prices for the last five trading days, on April 19, 2024, ATNM opened at $6.64, traded as high as $7.01 and as low as $6.60, and closed at $6.85. Trading volume was a total of 347.60K shares. On April 22, 2024, ATNM opened at $6.92, traded as high as $7.34 and as low as $6.82, and closed at $7.17. Trading volume was a total of 192.60K shares. On April 23, 2024, ATNM opened at $7.03, traded as high as $7.43 and as low as $6.85, and closed at $6.96. Trading volume was a total of 185.20K shares. On April 24, 2024, ATNM opened at $6.93, traded as high as $7.32 and as low as $6.88, and closed at $7.06. Trading volume was a total of 153.40K shares. On April 25, 2024, ATNM opened at $6.96, traded as high as $6.97 and as low as $6.47, and closed at $6.56. Trading volume was a total of 328.80K shares.
ATNM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Actinium Pharmaceuticals shares, starting with a $10,000 purchase of ATNM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$330.00 |
|
End price/share: |
$6.56 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.01% |
|
Average Annual Total Return: |
-32.42% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$198.91 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $6.85 | 04/22/2024 | $7.17 | 04/23/2024 | $6.96 | 04/24/2024 | $7.06 | 04/25/2024 | $6.56 |
|
|